Clinical Trials Directory

Trials / Unknown

UnknownNCT04109352

Labelled Carbon Sucrose Breath Test (13C-SBT) as a Marker of Environmental Enteropathy

Validation and Field-applicability of a 13C-Sucrose Breath Test to Assess Carbohydrate Uptake and Utilization in Environmental Enteropathy Among Children in Resource Poor Settings: A Multi-site Prospective Study

Status
Unknown
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
University of Virginia · Academic / Other
Sex
All
Age
12 Months – 15 Months
Healthy volunteers

Summary

Linear growth failure, a manifestation of chronic undernutrition in early childhood, is a recalcitrant problem in resource constrained settings. The underlying causes of growth failure are multifactorial, but persistent and recurrent infection and inflammation of the gastrointestinal tract and immune activation, a condition commonly referred to as environmental enteropathy, is an important contributor. A highly enriched 13C-Sucrose Breath Test, a measure of sucrase-isomaltase activity, will be evaluated as a non-invasive biomarker of environmental enteropathy, and more specifically of intestinal brush border enzyme activity in 6 resource poor countries (Bangladesh, India, Jamaica, Kenya, Peru and Zambia) in 100 volunteers aged 12-15 months (total n=600) and evaluated relative to the lactose rhamnose test and linear and ponderal growth over a 3-6 month period following biomarker assessment. Field usability will also be assessed.

Detailed description

Environmental enteropathy is associated with linear and ponderal growth shortfalls in young children in resource constrained settings. However, the physiological alterations of intestinal function that accompany both the demonstrable evidence of inflammation and architectural changes seen in biopsies from effected children have yet to be elucidated, and this knowledge gap limits the development of effective strategies to optimally manage the condition. Furthermore, a limited number of non-invasive assays exist with which to assess the presence of environmental enteropathy in low resource settings. This study aims 1) to determine if sucrose-isomaltase enzyme is altered in children with environmental enteropathy by using a 13C-Sucrose breath test 2) to determine if the test is able to be employed in resource limited settings.

Conditions

Timeline

Start date
2019-09-01
Primary completion
2022-07-01
Completion
2022-12-01
First posted
2019-09-30
Last updated
2021-10-06

Locations

9 sites across 8 countries: Australia, Bangladesh, India, Jamaica, Kenya, Peru, United Kingdom, Zambia

Source: ClinicalTrials.gov record NCT04109352. Inclusion in this directory is not an endorsement.